Trial is being conducted as part of a £90m Department of Health and Social Care (DHSC) initiative
Trial is being conducted as part of a £90m Department of Health and Social Care (DHSC) initiative
Phase II/III trial of the drug did not meet its futility criteria of the annualised rate change in total kidney volume (TKV)
KHK4083 is an anti-OX40, fully human monoclonal antibody in development for the treatment of atopic dermatitis
UK’s Vaccine Taskforce has secured 20 million doses of the vaccine, with initial deliveries expected ‘later this year’
Tremfya has already been recommended for NHS use to treat eligible patient with moderate-to-severe plaque psoriasis
Clinical diagnostics company said dispute may have a material impact on its Q1 revenues
Latest NHS waiting list figures show that 4.95 million people are currently waiting for elective surgery
In Phase III, adjuvant treatment with Tagrisso reduced the risk of disease recurrence or death by 80% in the overall population
New patient-reported outcomes data also shows Erleada did not worsen side effect burden
Strategy “marks a shift away from organisations and towards service improvement”
Once-daily treatment has been approved for the management of heavy menstrual bleeding
The study will include more than 35,000 volunteers aged 18 years and older
The 2021 Communications Awards have expanded to include two brand new medical affairs categories.
Digital health company said it would use the latest funding to research and identify new areas of help and develop its platform further
Scheme will enable Roche’s supply chain partners to purchase 100% renewable energy